Drugs / NORTASE®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06058442 | Jan 2024 → Jun 2027 expected | postgastrectomy syndrome | University of Leipzig | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NORTASE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06058442 ↗ |